1H-MRSI of Radiation Effects in Normal-appearing White Matter: Dose-dependence and Impact on Automated Spectral Classification
Overview
Affiliations
Purpose: To identify radiation-induced changes in healthy white-matter spectra in the first six months following radiotherapy, and assess the impact of these changes on an automated algorithm for detecting spectral abnormalities.
Materials And Methods: 1H-MRSI was performed on 10 patients with grade IV gliomas who were to undergo radiation therapy. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) ratios were studied as a function of dose and time. The impact of these spectral changes on a spectral analysis algorithm was evaluated.
Results: The Cho/NAA ratios rose to values of 0.66 +/- 0.15, 0.75 +/- 0.21, and 0.73 +/- 0.15 two months after therapy, compared to immediate post-therapy values of 0.56 +/- 0.15, 0.60 +/- 0.16, and 0.61 +/- 0.15 for the < 25, 25-50, and > 50 Gy dose groups, respectively. These maxima were followed by a dose-dependent recovery. A similar trend was found in the Cho/Cr ratio. The automated spectral analysis system incorporated the changing Cho/NAA ratio into a global redefinition of healthy tissue, but did not account for dose-dependent spatial variations in Cho/NAA ratios.
Conclusion: Radiation significantly alters the spectra of healthy tissues in the first six months after radiotherapy. This suggests that the radiation dose distribution should be considered during analysis of post-therapy spectra.
Petr J, Hogeboom L, Nikulin P, Wiegers E, Schroyen G, Kallehauge J MAGMA. 2021; 35(1):163-186.
PMID: 34919195 PMC: 8901489. DOI: 10.1007/s10334-021-00985-2.
MR Image Changes of Normal-Appearing Brain Tissue after Radiotherapy.
Witzmann K, Raschke F, Troost E Cancers (Basel). 2021; 13(7).
PMID: 33805542 PMC: 8037886. DOI: 10.3390/cancers13071573.
Biomarkers of Brain Damage Induced by Radiotherapy.
Sultana N, Sun C, Katsube T, Wang B Dose Response. 2020; 18(3):1559325820938279.
PMID: 32694960 PMC: 7350401. DOI: 10.1177/1559325820938279.
Brain MR findings in patients treated with particle therapy for skull base tumors.
Viselner G, Farina L, Lucev F, Turpini E, Lungarotti L, Bacila A Insights Imaging. 2019; 10(1):94.
PMID: 31549243 PMC: 6757093. DOI: 10.1186/s13244-019-0784-9.
Chen W, Li J, Hong L, Xing Z, Wang F, Li C Biomed Res Int. 2016; 2016:5126074.
PMID: 26953103 PMC: 4756187. DOI: 10.1155/2016/5126074.